Results 201 to 210 of about 38,272 (314)

Dapagliflozin enhances gut barrier function in rats with chronic myocardial infarction by modulating gut microbiota balance. [PDF]

Ann Transl Med
Kunasol C, Maneechote C, Apaijai N, Thonusin C, Parbao C, Nawara W, Chattipakorn N, Chattipakorn SC.   +7 more
europepmc   +1 more source

Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non-Diabetic Patient With Cardiac Amyloidosis. [PDF]

Clin Case Rep
Hamoud SAS, Harding E.
europepmc   +1 more source

Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis

Zeinab Seif El-Din, Mohammed Afify, Essam Zayed, Dalia Elsabaawy, El Sayed Tharwa, Ahmed A. ElSharawy, Eman Abdelsameea, Mohamed Akl Rady   +7 more
openalex   +1 more source

The impact of short-term administration of dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes and renal insufficiency undergoing percutaneous coronary intervention. [PDF]

Front Med (Lausanne)
Yang S, Zhu S, Zhai X, Liu M, Zhang P, Fu N.   +5 more
europepmc   +1 more source

Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction. [PDF]

Cardiol Res
Tsudome R, Suematsu Y, Tashiro K, Ideishi A, Miyazaki M, Yano Y, Arimura T, Hirata T, Fujimi K, Miura SI.   +9 more
europepmc   +1 more source

Dapagliflozin To Prevent the Incidence of Contrast Induced Nephropathy after Heart Catheterization and Percutaneous Coronary Intervention

openalex   +1 more source

The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance. [PDF]

Pediatr Diabetes
Attia N, Al Noaim K, Mustafa M, Al Fifi SH, Al Alwan I, Thalange N, Babiker A.   +6 more
europepmc   +1 more source

Dapagliflozin Preserves Peripheral Nerve Structure and Reduces Neuropathic Damage in Streptozotocin-Induced Diabetic Peripheral Neuropathy. [PDF]

Int J Mol Sci
Țucă AM, Preda AN, Târtea G, Hădăreanu DR, Țieranu E, Dan AO, Târtea EA, Greșiță A, Pîrșcoveanu DFV, Sfredel V, Mitran SI.   +10 more
europepmc   +1 more source

Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome [PDF]

Raymond Chuen‐Chung Chang, Ryan Miller, Katherine Kwon, Joanna Huang   +3 more
openalex   +1 more source

Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial. [PDF]

JACC Adv
Tavares CAM, Azevedo LCP, Guimarães PO, Rea-Neto Á, David-João PG, Campos NS, Amendola CP, Kozesinski-Nakatani AC, Filiponi TC, Almeida GMB, Bergo RR, Lobo SM, Tognon AP, Tavares MS, Silveira FS, Dracoulakis MDA, Biondi RS, Monfardini F, Nieri J, Madrini V, Serpa-Neto A, Bacal F, Lemos PA, Berwanger O, Ezekowitz JA, Zampieri FG, DEFENDER Investigators.   +26 more
europepmc   +1 more source